News and Trends 24 Oct 2022
Beckley Psytech acquires Eleusis Therapeutics
Beckley Psytech Limited has entered into a definitive agreement to acquire clinical-stage life science company Eleusis Therapeutics Limited in an…
Psychiatric disorders
- Latest Posts
News and Trends 4 Oct 2022
Spinoff Biohaven launches with $258M and “incredible pipeline”
Biohaven Ltd. launched today as a new publicly traded company focused on delivering innovative life-changing treatments for neurological and neuropsychiatric…
News and Trends 25 Jul 2022
Drug for acute treatment of social anxiety disorder did not meet primary endpoint
A nasal spray to treat anxiety did not meet its primary endpoint and was not significantly better than the placebo…
Best in Biotech 22 Jun 2022
The top psychedelic drug developers leading the market
Psychedelic drugs have the potential to become an effective treatment for crippling mental health conditions such as depression. Here are…
ADVERTISEMENT
News and Trends 7 Dec 2020
Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures
In spite of recent failures of clinical trials from others in the field, Swiss company Noema Pharma is gearing up…
News and Trends 8 May 2019
Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood
Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia on single cells from a…
News and Trends 9 Oct 2018
Slow-Release Drug Biotech IPO Raises €30M
The French biotech MedinCell, an injectable slow-release drug specialist, has received a shot of success as its IPO raises €30M…
News and Trends 19 Dec 2017
Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner
Santa Claus is not the only busy one in the weeks leading up to Christmas this year, with Boehringer Ingelheim…
News and Trends 7 Nov 2017
British Researchers Find Thought Police to Treat Neurological Disorders
Cambridge University scientists have identified a chemical in the brain that blocks unwanted thoughts, offering a new avenue to treat neurological…
News and Trends 2 Jun 2017
Austrian Researchers build an improved Mini-Brain to support Psychiatry
Researchers from Austria and the UK have made new advances in engineering brain-like structures. These lab-grown organoids mimic important functions…
Interview 6 Feb 2017
“We want to be the Worldwide Leader in Microbiota”
Biotech entrepreneur Hervé Affagard, CEO of MaaT Pharma, tells the story behind the success of his young microbiome company. Hervé…
News and Trends 2 Dec 2016
Mind, Mood and Microbes: Harnessing the Power of Probiotics
The canals of Amsterdam have attracted us this week to the capital of the Netherlands, where Winclove Probiotics has been…
News and Trends 30 Nov 2016
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
Heptares Therapeutics has acquired G7 Therapeutics to take control over its GPCR technology, boost its pipeline and keep competitors in…
News and Trends 11 Oct 2016
World Mental Health Day: How is Biotech Helping the Cause?
Biotech is one of the main forces driving the development of effective therapies to treat neurological and mental disorders. For World Mental…
News and Trends 14 Jun 2016
New Biomarkers could make Personalized Medicine for Depression
Researchers from King’s College London have succeeded in developing a blood test that can help choose the best treatment for depression…
News and Trends 16 Feb 2016
Sorry Scotland, Phase II Trial for Clinical Depression Fails against 55-Year Old Generic
I mean, Clinical depression is a tough indication for Biotech to tackle - particularly when facing off a '55-year old' generic…
ADVERTISEMENT
News and Trends 8 Jan 2016
Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists
Founded in just 2013 by German Proteros and the US Atlas Ventures, Rodin Therapeutics is working epigenetics into discovery of…
News and Trends 6 Jan 2016
Growing Mini-Brains in Labs to Better Understand Neurological Disease
Mini brains, about 3-4 mm are a breakthrough in Neurology which will enable researchers to study the development of neurological…
News and Trends 10 May 2015
Succesful Phase III for Indivior’s Schizophrenia treatment
Indivior obtained top-line results from its phase III clinical trial of RBP-7000, a candidate treatment for schizophrenia. Based on these…
News and Trends 2 May 2015
Newron raised new funds to continue the development of Neurological therapies
Newron Pharmaceuticals, a public company focused on novel Central Nervous System (CNS) and pain therapies, announces that it has completed a…
